pk 11195 has been researched along with Granulocytic Leukemia in 3 studies
PK-11195 : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 1-(2-chlorophenyl)isoquinoline-3-carboxylic acid with the amino group of sec-butylmethylamine
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jakubikova, J | 1 |
| Duraj, J | 1 |
| Hunakova, L | 1 |
| Chorvath, B | 1 |
| Sedlak, J | 1 |
| Walter, RB | 1 |
| Raden, BW | 1 |
| Cronk, MR | 1 |
| Bernstein, ID | 1 |
| Appelbaum, FR | 2 |
| Banker, DE | 2 |
| Cooper, JJ | 1 |
| Fennell, DA | 1 |
| Willman, CL | 1 |
| Cotter, FE | 1 |
3 other studies available for pk 11195 and Granulocytic Leukemia
| Article | Year |
|---|---|
PK11195, an isoquinoline carboxamide ligand of the mitochondrial benzodiazepine receptor, increased drug uptake and facilitated drug-induced apoptosis in human multidrug-resistant leukemia cells in vitro.
Topics: Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biologica | 2002 |
The peripheral benzodiazepine receptor ligand PK11195 overcomes different resistance mechanisms to sensitize AML cells to gemtuzumab ozogamicin.
Topics: Acute Disease; Aminoglycosides; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; | 2004 |
PK11195, a peripheral benzodiazepine receptor ligand, chemosensitizes acute myeloid leukemia cells to relevant therapeutic agents by more than one mechanism.
Topics: Acute Disease; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; | 2002 |